CNY 1.87
(-1.57%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -346.79 Million CNY | -44.32% |
2022 | -240.29 Million CNY | 38.22% |
2021 | -388.98 Million CNY | -5.52% |
2020 | -368.61 Million CNY | 78.88% |
2019 | -1.74 Billion CNY | -1206.51% |
2018 | 157.77 Million CNY | -38.41% |
2017 | 256.15 Million CNY | 47.9% |
2016 | 173.18 Million CNY | 20.16% |
2015 | 144.12 Million CNY | 143.54% |
2014 | 59.17 Million CNY | 120.73% |
2013 | 26.81 Million CNY | -17.03% |
2012 | 32.31 Million CNY | 5.19% |
2011 | 30.71 Million CNY | 12.24% |
2010 | 27.36 Million CNY | 17.05% |
2009 | 23.38 Million CNY | 46.55% |
2008 | 15.95 Million CNY | -6.02% |
2007 | 16.97 Million CNY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -65.78 Million CNY | -30.64% |
2024 Q1 | -50.35 Million CNY | 70.63% |
2024 Q3 | -91.65 Million CNY | -39.33% |
2023 Q3 | -61.93 Million CNY | 29.61% |
2023 Q1 | -25.42 Million CNY | -152.45% |
2023 Q2 | -87.98 Million CNY | -246.02% |
2023 Q4 | -171.44 Million CNY | -176.82% |
2023 FY | -346.79 Million CNY | -44.32% |
2022 FY | -240.29 Million CNY | 38.22% |
2022 Q1 | -45.63 Million CNY | 58.2% |
2022 Q2 | -177.22 Million CNY | -288.32% |
2022 Q3 | -65.91 Million CNY | 62.81% |
2022 Q4 | 48.48 Million CNY | 173.55% |
2021 Q3 | -53.09 Million CNY | 72.37% |
2021 Q2 | -192.14 Million CNY | -456.15% |
2021 Q1 | -34.54 Million CNY | 79.4% |
2021 FY | -388.98 Million CNY | -5.52% |
2021 Q4 | -109.19 Million CNY | -105.65% |
2020 Q2 | -42.49 Million CNY | -3.42% |
2020 Q4 | -167.72 Million CNY | -42.98% |
2020 FY | -368.61 Million CNY | 78.88% |
2020 Q3 | -117.3 Million CNY | -176.01% |
2020 Q1 | -41.09 Million CNY | 97.68% |
2019 Q1 | 35.84 Million CNY | 21.14% |
2019 FY | -1.74 Billion CNY | -1206.51% |
2019 Q4 | -1.76 Billion CNY | -43161.8% |
2019 Q3 | -4.09 Million CNY | 49.36% |
2019 Q2 | -8.07 Million CNY | -122.53% |
2018 Q1 | 44.26 Million CNY | -74.11% |
2018 FY | 157.77 Million CNY | -38.41% |
2018 Q4 | 29.59 Million CNY | -11.55% |
2018 Q3 | 33.45 Million CNY | -33.68% |
2018 Q2 | 50.44 Million CNY | 13.96% |
2017 FY | 256.15 Million CNY | 47.9% |
2017 Q1 | 14.35 Million CNY | -63.19% |
2017 Q3 | 28.64 Million CNY | -32.11% |
2017 Q4 | 170.96 Million CNY | 496.93% |
2017 Q2 | 42.18 Million CNY | 193.81% |
2016 FY | 173.18 Million CNY | 20.16% |
2016 Q3 | 57.99 Million CNY | 54.76% |
2016 Q2 | 37.47 Million CNY | -3.21% |
2016 Q1 | 38.71 Million CNY | 515.45% |
2016 Q4 | 39 Million CNY | -32.74% |
2015 Q1 | 42.47 Million CNY | 91.98% |
2015 Q2 | 50.35 Million CNY | 18.55% |
2015 Q3 | 46.54 Million CNY | -7.57% |
2015 FY | 144.12 Million CNY | 143.54% |
2015 Q4 | 6.29 Million CNY | -86.48% |
2014 Q4 | 22.12 Million CNY | 19.44% |
2014 FY | 59.17 Million CNY | 120.73% |
2014 Q3 | 18.52 Million CNY | 71.67% |
2014 Q2 | 10.79 Million CNY | 39.44% |
2014 Q1 | 7.73 Million CNY | 67.11% |
2013 Q1 | 4.55 Million CNY | 309.22% |
2013 FY | 26.81 Million CNY | -17.03% |
2013 Q2 | 13.28 Million CNY | 191.91% |
2013 Q3 | 4.33 Million CNY | -67.35% |
2013 Q4 | 4.63 Million CNY | 6.74% |
2012 Q4 | 1.11 Million CNY | -77.73% |
2012 Q1 | 9.27 Million CNY | 18.85% |
2012 FY | 32.31 Million CNY | 5.19% |
2012 Q3 | 4.99 Million CNY | -70.49% |
2012 Q2 | 16.92 Million CNY | 82.42% |
2011 Q1 | 6.41 Million CNY | -4.12% |
2011 Q2 | 9.71 Million CNY | 51.44% |
2011 Q3 | 6.78 Million CNY | -30.18% |
2011 Q4 | 7.8 Million CNY | 15.11% |
2011 FY | 30.71 Million CNY | 12.24% |
2010 Q4 | 6.69 Million CNY | 26.69% |
2010 Q2 | 9.73 Million CNY | 71.71% |
2010 Q3 | 5.28 Million CNY | -45.73% |
2010 FY | 27.36 Million CNY | 17.05% |
2010 Q1 | 5.66 Million CNY | -24.68% |
2009 Q4 | 7.52 Million CNY | 57.22% |
2009 Q3 | 4.78 Million CNY | 0.0% |
2009 FY | 23.38 Million CNY | 46.55% |
2008 FY | 15.95 Million CNY | -6.02% |
2007 FY | 16.97 Million CNY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Cachet Pharmaceutical Co., Ltd. | 733.77 Million CNY | 147.261% |
Yixintang Pharmaceutical Group Co., Ltd. | 786.44 Million CNY | 144.096% |
ZJAMP Group Co., Ltd. | 1.05 Billion CNY | 132.989% |
Luyan Pharma Co.,Ltd. | 468.55 Million CNY | 174.013% |